Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial.

2013

Objective To determine the safety and therapeutic effects of nimotuzumab (h-R3) combined with radiotherapy in esophageal cancer.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

43

References

33

Citations